Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: oral microbiome data from multiplex nasopharyngeal carcinoma families

PROVIDER: PRJNA1062097 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR27451300_1.fastq.gz	Fastqsanger.gz
	SRR27451300_2.fastq.gz	Fastqsanger.gz
	SRR27451400_1.fastq.gz	Fastqsanger.gz
	SRR27451400_2.fastq.gz	Fastqsanger.gz
	SRR27451500_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 1388

Similar Datasets

Project description:Longitudinal oral microbiome of patients with nasopharyngeal carcinoma

| PRJNA1194502 | ENA

Project description:Oral Microbiome Data of Oral Squamous Cell Carcinoma

| PRJNA666891 | ENA

mRNA expression profiling of nasopharyngeal carcinoma

Project description:Nasopharyngeal carcinoma is an Epstein-Barr virus-associated epithelial cancer with high prevalence in Southeast Asia. mRNA expression levels were measured for essentially all human genes in nasopharyngeal carcinoma tissue samples and normal nasopharyngeal tissues. Data were analyzed for differential gene expression between tumor and normal tissue.

2017-02-09 | GSE64634 | GEO

Project description:Oral microbiota of patients with nasopharyngeal carcinoma

| PRJNA721474 | ENA

HuMiChip analysis of 86 samples from different body sites

Project description:HuMiChip was used to analyze human oral and gut microbiomes, showing significantly different functional gene profiles between oral and gut microbiome. The results were used to demonstarte the usefulness of applying HuMiChip to human microbiome studies.

2014-02-04 | E-GEOD-54290 | biostudies-arrayexpress

Human nasopharyngeal carcinoma cells : S18 with high metastasis potential vs. S26 with low metastasis potential

Project description:Metastasis is the major reason of treatment failure in nasopharyngeal carcinoma. miRNAs have been identified to regulate tumor metastasis. We aimed to identify metastasis-associated miRNAs in nasopharyngeal carcinoma.

2020-02-24 | GSE137312 | GEO

SARS-CoV-2 Oropharyngeal and Nasopharyngeal samples

Project description:Microbiome analysis of oropharyngeal and nasopharyngeal samples of SARS-CoV-2 infected patients

2021-02-06 | GSE166281 | GEO

microRNA profiles of exosomes from two nasopharyngeal carcinoma cell line and nasopharyngeal epithelial cells

Project description:microRNA profiles of exosomes :Exosomes from two nasopharyngeal carcinoma cell line TW03M-oM-<M-^HEBV+M-oM-<M-^Iand TW03M-oM-<M-^HEBV-M-oM-<M-^I and Exosomes from nasopharyngeal epithelial cells NP69 Two-condition experiment, Exosomes from two nasopharyngeal carcinoma cell line vs.one normal epithelium cell line. Biological replicates:1 Exosomes from nasopharyngeal carcinoma cell line TW03M-oM-<M-^HEBV+M-oM-<M-^I, 1 Exosomes from nasopharyngeal carcinoma cell line TW03M-oM-<M-^HEBV-M-oM-<M-^I,1 Exosomes from nasopharyngeal epithelial cells NP69.

2014-05-07 | E-GEOD-57367 | biostudies-arrayexpress

A Study of Lymphangiogenesis in Colorectal and Nasopharyngeal Cancer

Project description:1. To determine the association between LVD and clinico-pathologic variables in archived colorectal cancer and Nasopharyngeal carcinoma specimens 2. To determine the association between VEGF-C,-D expression with COX-2 expression and clinico-pathologic variables in colorectal cancer and Nasopharyngeal carcinoma 3. To determine the effect of celecoxib on lymphangiogenesis in Nasopharyngeal carcinoma Lymphangiogenesis and factors modulating lymphangiogenesis are associated with clinico-pathological outcome in Nasopharyngeal carcinoma and colorectal cancer. Celecoxib down-regulates lymphangiogenesis Archival colorectal cancer and Nasopharyngeal carcinoma tumor specimens will be obtained from the Department of Pathology. To determine the effect of celecoxib on lymphangiogenesis in Nasopharyngeal carcinoma, the investigators intend to analyze archived specimens collected in a previously conducted study. Colorectal tumor and nodal specimens and Nasopharyngeal carcinoma primary will be examined for MVD, LVD and growth factor expression using established haematoxylin and eosin and immunohistochemical techniques. Quantification of LVD and MVD shall be performed by two pathologists blinded to clinico-pathological variables using standardised methods.

| 2075499 | ecrin-mdr-crc

Project description:Microbiome in microenvironment of nasopharyngeal carcinoma

| PRJNA974230 | ENA